Luiza Aggio
Research Subjects
Luiza Aggio has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Cristiano Soleo Funari
São Paulo State University (UNESP), Faculty of Agricultural Sciences, Botucatu, São Paulo, Brazil
1 shared publication - Cristina Viriato
Center for Evaluation of Environmental Impact on Human Health (TOXICAM), Botucatu 18618-687, Brazil
1 shared publication - Didier Quevedo Cagnini
School of Veterinary Medicine and Animal Science, São Paulo State University - UNESP, Botucatu, Brazil
1 shared publication - Emanuelle Gomes de Oliveira1 shared publication
- José Carlos Figueiredo Pantoja
Department of Animal Production and Preventive Veterinary Medicine, School of Veterinary Medicine and Animal Science (FMVZ), São Paulo State University (UNESP), Prof. Dr. Walter Mauricio Correa Street, Botucatu 18618-681, SP, Brazil
1 shared publication - Lilian Cristina Pereira
Medical School, São Paulo State University (Unesp), Botucatu 18618-687, Brazil
1 shared publication
Latest Publications
- Open Access
- 11 February 2026
- Published by Elsevier in SSRN Electronic Journal
Evaluation of the mutagenicity, genotoxicity and histopathology of adult zebrafish (Danio rerio) chronically exposed to the herbicide 2,4-D and its commercial formula (dimethylamine salt)
The objective of this present study was to evaluate the sub-lethal effects of 2,4-D herbicide and its commercial formula in zebrafish (Danio rerio) adults chronically exposed in relevant environmental concentrations. The fish were exposed to 0.1, 5, and 30 µM of 2,4-D and DMA 806 for 3 months, with solution renewals every 7 days. We analyzed genotoxicity and mutagenicity through the micronucleus (MN) assay, chromosomal instability by quantifying nuclear abnormalities and histopathological alterations of the kidney and liver using H&E staining. We found no significant difference in the relative frequency of MN, which means both 2,4-D and DMA 806 are not mutagenic for zebrafish chronically exposed to these substances. However, there was a significant difference in the relative frequency of total nucleus abnormalities to both substances’ treatments. Lobed nuclei (LN) were the most found, even in relevant environmental concentrations to the commercial formula DMA 806. For histopathological analysis, it was also found a significant difference in kidney and liver index alterations for both 2,4-D acid and DMA 806 treatments compared to the negative control. The commercial formula treatments showed the highest index results, also indicating that it is more toxic than the active ingredient. It can be concluded that in this case, the commercial formula DMA 806, in the salt form of 2,4-D acid, has more potential to be genotoxic and to cause injuries to liver and kidney tissues.
- 11 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEvaluation of the mutagenicity, genotoxicity and histopathology of adult zebrafish (Danio rerio) chronically exposed to the herbicide 2,4-D and its commercial formula (dimethylamine salt)
The objective of this present study was to evaluate the sub-lethal effects of 2,4-D herbicide and its commercial formula in zebrafish (Danio rerio) adults chronically exposed in relevant environmental concentrations. The fish were exposed to 0.1, 5, and 30 µM of 2,4-D and DMA 806 for 3 months, with solution renewals every 7 days. We analyzed genotoxicity and mutagenicity through the micronucleus (MN) assay, chromosomal instability by quantifying nuclear abnormalities and histopathological alterations of the kidney and liver using H&E staining. We found no significant difference in the relative frequency of MN, which means both 2,4-D and DMA 806 are not mutagenic for zebrafish chronically exposed to these substances. However, there was a significant difference in the relative frequency of total nucleus abnormalities to both substances’ treatments. Lobed nuclei (LN) were the most found, even in relevant environmental concentrations to the commercial formula DMA 806. For histopathological analysis, it was also found a significant difference in kidney and liver index alterations for both 2,4-D acid and DMA 806 treatments compared to the negative control. The commercial formula treatments showed the highest index results, also indicating that it is more toxic than the active ingredient. It can be concluded that in this case, the commercial formula DMA 806, in the salt form of 2,4-D acid, has more potential to be genotoxic and to cause injuries to liver and kidney tissues.